The effect of immunity to core lipopolysaccharides (LPS) on the production of thromboxane and prostacyclin by equine peritoneal macrophages.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research studied the impact of heightened immunity to certain bacterial components (lipopolysaccharides) on the production of clotting agents and blood vessel influencers in horse peritoneal macrophages, tying it to the potential onset of immunity to certain bacterial infections.
Overview of the Research
The study’s main goal was to understand whether a change in macrophages’ responses to bacteria elements, specifically lipopolysaccharides (LPS) from gram-negative bacteria, was a factor in the onset of cross-reactive immunity to endotoxemia. Endotoxemia is a condition characterized by the presence of endotoxins (toxins present inside bacterial cells and released when destroyed) in the blood, leading to systemic inflammatory responses.
Methodology
- A comparison of the production of thromboxane A2 (TxA2) and prostacyclin (PGI2) was made. These two substances are produced by peritoneal macrophages and play crucial roles in regulating blood flow and clotting.
- The cells used for analysis were sourced from horses that were hyperimmunized against the common core region of LPS, as well as from non-immunized horses.
- The researchers prepared the bacteria used to induce core LPS immunity from potent Escherichia coli and Salmonella Minnesota strains.
- The serum antibody levels against core LPS in the horses’ blood were assessed using an enzyme-linked immunosorbent assay.
Findings
- Immunized horses showed a significant increase in antibodies against the core LPS, compared to non-immunized horses. However, the only significant difference found was that immunized horses’ peritoneal macrophages produced more TxA2 in response to LPS.
- This finding seemingly contradicts the idea that cross-reactive immunity to LPS leads to a decreased production of TxA2 and PGI2.
Significance
These results suggest that heightened immunity to LPS does not significantly diminish the production of TxA2 and PGI2, which play essential roles in blood flow regulation and clotting. This observation refutes the hypothesis that cross-reactive immunity to LPS results in a reduced production of these substances in equine peritoneal macrophages, thus giving us more insight into the immune response mechanisms.
Cite This Article
Publication
Researcher Affiliations
- Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens 30602.
MeSH Terms
- Animals
- Antibodies, Bacterial / biosynthesis
- Cross Reactions
- Endotoxins / blood
- Epoprostenol / biosynthesis
- Escherichia coli
- Horses
- Immunoglobulin G / biosynthesis
- Lipopolysaccharides / immunology
- Macrophages / immunology
- Salmonella
- Thromboxane A2 / biosynthesis